[HTML][HTML] A global review on short peptides: frontiers and perspectives

V Apostolopoulos, J Bojarska, TT Chai, S Elnagdy… - Molecules, 2021 - mdpi.com
Peptides are fragments of proteins that carry out biological functions. They act as signaling
entities via all domains of life and interfere with protein-protein interactions, which are …

[HTML][HTML] An update on angiotensin-converting enzyme 2 structure/functions, polymorphism, and duplicitous nature in the pathophysiology of coronavirus disease 2019 …

CA Devaux, L Camoin-Jau - Frontiers in Microbiology, 2022 - frontiersin.org
It has been known for many years that the angiotensin-converting enzyme 2 (ACE2) is a cell
surface enzyme involved in the regulation of blood pressure. More recently, it was proven …

[HTML][HTML] Role of angiotensin ii in cardiovascular diseases: introducing bisartans as a novel therapy for coronavirus 2019

J Swiderski, LK Gadanec, V Apostolopoulos, GJ Moore… - Biomolecules, 2023 - mdpi.com
Cardiovascular diseases (CVDs) are the main contributors to global morbidity and mortality.
Major pathogenic phenotypes of CVDs include the development of endothelial dysfunction …

[HTML][HTML] Molecular epidemiology of SARS-CoV-2: the dominant role of arginine in mutations and infectivity

H Ridgway, C Ntallis, CT Chasapis, K Kelaidonis… - Viruses, 2023 - mdpi.com
Background, Aims, Methods, Results, Conclusions: Severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2) is a global challenge due to its ability to mutate into variants …

[HTML][HTML] Diminazene aceturate reduces angiotensin II constriction and interacts with the spike protein of severe acute respiratory syndrome coronavirus 2

JM Matsoukas, LK Gadanec, A Zulli, V Apostolopoulos… - Biomedicines, 2022 - mdpi.com
Diminazene aceturate (DIZE) is a putative angiotensin-converting enzyme 2 (ACE2)
activator and angiotensin type 1 receptor antagonist (AT1R). Its simple chemical structure …

Dual targeting of Toll-like receptor 4 and angiotensin-converting enzyme 2: A proposed approach to SARS-CoV-2 treatment

L Kate Gadanec, T Qaradakhi… - Future …, 2021 - Future Medicine
The occurrence of the SARS-CoV-2, the virus responsible for COVID-19, has rapidly
become a pandemic, resulting in devastating effects to the global economy and public …

[HTML][HTML] From angiotensin II to cyclic peptides and angiotensin receptor blockers (ARBs): Perspectives of ARBs in COVID-19 therapy

J Matsoukas, V Apostolopoulos, A Zulli, G Moore… - Molecules, 2021 - mdpi.com
The octapeptide hormone angiotensin II is one of the most studied peptides with the aim of
designing and synthesizing non-peptide mimetics for oral administration. To achieve this …

[HTML][HTML] Diminazene aceturate stabilizes atherosclerotic plaque and attenuates hepatic steatosis in apoE-knockout mice by influencing macrophages polarization and …

A Stachowicz, A Wiśniewska, K Kuś, M Białas… - International journal of …, 2021 - mdpi.com
Atherosclerosis and nonalcoholic fatty liver disease are leading causes of morbidity and
mortality in the Western countries. The renin–angiotensin system (RAS) with its two main …

ACE2 improves endothelial cell function and reduces acute lung injury by downregulating FAK expression

Y He, B Gang, M Zhang, Y Bai, Z Wan, J Pan… - International …, 2024 - Elsevier
Endothelial cell (EC) barrier dysfunction and increased adhesion of immune inflammatory
cells to ECs crucially contribute to acute lung injury (ALI). Angiotensin-converting enzyme 2 …

[HTML][HTML] Decoy peptides effectively inhibit the binding of SARS-CoV-2 to ACE2 on oral epithelial cells

LK Loi, CC Yang, YC Lin, YF Su, YC Juan, YH Chen… - Heliyon, 2023 - Elsevier
The entry of SARS-CoV-2 into host cells involves the interaction between the viral spike
protein and the human angiotensin-converting enzyme 2 (ACE2) receptor. Given that the …